Entrada Therapeutics (TRDA) Income Statement (2020 - 2026)
Income Statement report data from Mar 31, 2020 to Mar 31, 2026 for Entrada Therapeutics (TRDA).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||
Total Revenue | 880K (-32.31%) | 1.30M (-19.25%) | 1.61M (-17.44%) | 1.95M (-90.52%) | 21M (-45.03%) | 37M (+91.11%) | 20M (-79.33%) | 95M (+60.17%) | 59M (+41.27%) | 42M (-4.32%) | 44M (+140.73%) | 18M (-28.07%) | 25M | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | |||||||||||||||||||||||||
Research And Development | 33M (-2.68%) | 34M (-11.47%) | 38M (+1.27%) | 38M (+18.12%) | 32M (-4.01%) | 33M (+6.88%) | 31M (-2.40%) | 32M (+11.95%) | 29M (+1.13%) | 28M (+27.49%) | 22M (-15.63%) | 26M (+13.85%) | 23M (+47.23%) | 16M (-17.25%) | 19M (+16.68%) | 16M (+3.37%) | 16M (+27.18%) | 12M (+17.60%) | 11M (+53.88%) | 6.83M (+9.81%) | 6.22M (-59.61%) | 15M (+170.18%) | 5.70M | - | - |
Selling General And Administrative | 10M (+5.97%) | 9.55M (-7.28%) | 10M (-5.68%) | 11M (+6.33%) | 10M (+4.16%) | 9.86M (-1.10%) | 9.97M (+7.90%) | 9.24M (-1.70%) | 9.40M (+8.67%) | 8.65M (+14.87%) | 7.53M (-7.83%) | 8.17M (+2.90%) | 7.94M (-19.72%) | 9.89M (+41.69%) | 6.98M (-4.77%) | 7.33M (+14.00%) | 6.43M (+5.41%) | 6.10M (+58.44%) | 3.85M (+25.00%) | 3.08M (+41.94%) | 2.17M (-49.42%) | 4.29M (+237.80%) | 1.27M | - | - |
Operating Expenses | 43M (-0.76%) | 44M (-10.60%) | 49M (-0.27%) | 49M (+15.23%) | 42M (-2.13%) | 43M (+4.95%) | 41M (-0.10%) | 41M (+8.58%) | 38M (+2.90%) | 37M (+24.29%) | 30M (-13.78%) | 34M (+11.05%) | 31M (+21.34%) | 26M (-1.39%) | 26M (+10.01%) | 24M (+6.46%) | 22M (+19.99%) | 18M (+28.55%) | 14M (+44.90%) | 9.91M (+18.12%) | 8.39M (-57.39%) | 20M (+182.50%) | 6.97M | - | - |
Depreciation And Amortization | 810K (-4.71%) | 850K (-29.17%) | 1.20M (+9.09%) | 1.10M (+15.79%) | 950K (-8.65%) | 1.04M (+15.56%) | 900K (0.00%) | 900K (-3.23%) | 930K (+16.25%) | 800K (0.00%) | 800K (+14.29%) | 700K (+29.63%) | 540K (+5.88%) | 510K (+2.00%) | 500K (0.00%) | 500K (+28.21%) | 390K (+21.88%) | 320K (+6.67%) | 300K (0.00%) | 300K (+50.00%) | 200K (-13.04%) | 230K (+130.00%) | 100K | - | - |
Operating Income | |||||||||||||||||||||||||
Operating Income | -42.30M (+0.21%) | -42.21M (-10.29%) | -47.05M (+0.43%) | -46.85M (+115.01%) | -21.79M (+271.21%) | -5.87M (-72.90%) | -21.66M | 53M (+153.06%) | 21M (+329.94%) | 4.91M (-64.95%) | 14M | -16.30M (+182.01%) | -5.78M (-77.40%) | -25.58M (-1.39%) | -25.94M (+10.01%) | -23.58M (+6.46%) | -22.15M (+19.99%) | -18.46M (+28.55%) | -14.36M (+44.90%) | -9.91M (+18.12%) | -8.39M (-57.39%) | -19.69M (+182.50%) | -6.97M | - | - |
Ebit | -42.30M (+0.21%) | -42.21M (-10.29%) | -47.05M (+0.43%) | -46.85M (+115.01%) | -21.79M (+271.21%) | -5.87M (-72.90%) | -21.66M | 53M (+153.06%) | 21M (+329.94%) | 4.91M (-64.95%) | 14M | -16.30M (+182.01%) | -5.78M (-77.40%) | -25.58M (-1.39%) | -25.94M (+10.01%) | -23.58M (+6.46%) | -22.15M (+19.99%) | -18.46M (+28.55%) | -14.36M (+44.90%) | -9.91M (+18.12%) | -8.39M (-4.98%) | -8.83M (+26.69%) | -6.97M (+12.97%) | -6.17M (+31.56%) | -4.69M |
EBITDA | -41.50M (+0.34%) | -41.36M (-9.79%) | -45.85M (+0.22%) | -45.75M (+119.53%) | -20.84M (+331.47%) | -4.83M (-76.73%) | -20.76M | 54M (+146.35%) | 22M (+286.16%) | 5.71M (-61.44%) | 15M | -15.60M (+197.71%) | -5.24M (-79.10%) | -25.07M (-1.45%) | -25.44M (+10.23%) | -23.08M (+6.07%) | -21.76M (+19.96%) | -18.14M (+29.02%) | -14.06M (+46.31%) | -9.61M (+17.34%) | -8.19M (-4.88%) | -8.61M (+25.33%) | -6.87M (+11.35%) | -6.17M (+31.56%) | -4.69M |
Other Income / Expenses | |||||||||||||||||||||||||
Other Non Operating Income | 2.62M (-82.61%) | 15M (+322.13%) | 3.57M (-8.93%) | 3.92M (-11.71%) | 4.44M (-77.20%) | 19M (+237.44%) | 5.77M (+32.04%) | 4.37M (+3.80%) | 4.21M (-72.34%) | 15M (+275.80%) | 4.05M (-4.03%) | 4.22M (+58.65%) | 2.66M (+1.14%) | 2.63M (+228.75%) | 800K (+100.00%) | 400K (-16.67%) | 480K | -30.00K (-57.14%) | -70.00K | 10K (0.00%) | 10K (-92.86%) | 140K | -20.00K | - | - |
Net Income | |||||||||||||||||||||||||
Income Tax Expense | 40K (-55.56%) | 90K (-86.15%) | 650K (+261.11%) | 180K | - | -1.87M (+0.54%) | -1.86M | 2.76M (+50.82%) | 1.83M (-90.23%) | 19M | -17.40M | 14M (+290.14%) | 3.55M | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income From Continuing Operations | -39.72M (+1.43%) | -39.16M (-11.26%) | -44.13M (+2.39%) | -43.10M (+148.41%) | -17.35M | 1.13M | -14.03M | 55M (+134.17%) | 24M | -9.54M | 35M | -25.93M (+288.76%) | -6.67M (-72.92%) | -24.63M (-2.03%) | -25.14M (+8.46%) | -23.18M (+6.97%) | -21.67M (+17.45%) | -18.45M (+27.86%) | -14.43M (+45.76%) | -9.90M (+18.14%) | -8.38M (-3.34%) | -8.67M (+24.03%) | -6.99M (+13.29%) | -6.17M (+31.56%) | -4.69M |
Net Income | -39.72M (+1.43%) | -39.16M (-11.26%) | -44.13M (+2.39%) | -43.10M (+148.41%) | -17.35M | 1.13M | -14.03M | 55M (+134.17%) | 24M | -9.54M | 35M | -25.93M (+288.76%) | -6.67M (-72.92%) | -24.63M (-2.03%) | -25.14M (+8.46%) | -23.18M (+6.97%) | -21.67M (+17.45%) | -18.45M (+27.86%) | -14.43M (+45.76%) | -9.90M (+18.14%) | -8.38M (-3.34%) | -8.67M (+24.03%) | -6.99M (+13.29%) | -6.17M (+31.56%) | -4.69M |
Comprehensive Income Net Of Tax | -40.12M (-71.95%) | -143.05M (+225.78%) | -43.91M (+1.78%) | -43.14M (+155.72%) | -16.87M | 65M | -12.73M | 55M (+138.29%) | 23M | -4.43M | 36M | -26.29M (+399.81%) | -5.26M (-94.56%) | -96.67M (+277.32%) | -25.62M (+7.15%) | -23.91M (+3.02%) | -23.21M (-54.63%) | -51.16M (+254.54%) | -14.43M (+45.76%) | -9.90M (+18.14%) | -8.38M | - | - | - | - |